{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:55Z","timestamp":1786980295455,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Boryung Pharmaceutical Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00520-024-08430-5","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T04:04:21Z","timestamp":1711425861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database"],"prefix":"10.1007","volume":"32","author":[{"given":"Chang Min","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Il","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"issue":"5","key":"8430_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495","journal-title":"Lancet Oncol"},{"issue":"6","key":"8430_CR2","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/jcsm.12837","volume":"12","author":"SI Go","year":"2021","unstructured":"Go SI, Park MJ, Park S, Kang MH, Kim HG, Kang JH et al (2021) Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma. J Cachexia Sarcopenia Muscle 12(6):2211\u20132219","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"8430_CR3","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","volume":"90","author":"AW Moses","year":"2004","unstructured":"Moses AW, Slater C, Preston T, Barber MD, Fearon KC (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90(5):996\u20131002","journal-title":"Br J Cancer"},{"issue":"11","key":"8430_CR4","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1007\/s00520-016-3287-y","volume":"24","author":"D Srdic","year":"2016","unstructured":"Srdic D, Plestina S, Sverko-Peternac A, Nikolac N, Simundic AM, Samarzija M (2016) Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value. Support Care Cancer 24(11):4495\u20134502","journal-title":"Support Care Cancer"},{"issue":"7","key":"8430_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","volume":"67","author":"L Sun","year":"2015","unstructured":"Sun L, Quan XQ, Yu S (2015) An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status. Nutr Cancer 67(7):1056\u20131062","journal-title":"Nutr Cancer"},{"issue":"6","key":"8430_CR6","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/jcsm.12776","volume":"12","author":"J Poisson","year":"2021","unstructured":"Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C et al (2021) Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle 12(6):1477\u20131488","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"8430_CR7","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.21873\/anticanres.14734","volume":"40","author":"H Fujii","year":"2020","unstructured":"Fujii H, Makiyama A, Iihara H, Okumura N, Yamamoto S, Imai T et al (2020) Cancer cachexia reduces the efficacy of nivolumab treatment in patients with advanced gastric cancer. Anticancer Res 40(12):7067\u20137075","journal-title":"Anticancer Res"},{"issue":"11","key":"8430_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s00595-022-02493-9","volume":"52","author":"T Namikawa","year":"2022","unstructured":"Namikawa T, Marui A, Yokota K, Fujieda Y, Munekage M, Uemura S et al (2022) Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patients. Surg Today 52(11):1560\u20131567","journal-title":"Surg Today"},{"issue":"5","key":"8430_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00520-008-0486-1","volume":"17","author":"D Churm","year":"2009","unstructured":"Churm D, Andrew IM, Holden K, Hildreth AJ, Hawkins C (2009) A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 17(5):503\u2013507","journal-title":"Support Care Cancer"},{"issue":"3","key":"8430_CR10","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","volume":"6","author":"J Arends","year":"2021","unstructured":"Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P et al (2021) Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines(). ESMO Open 6(3):100092","journal-title":"ESMO Open"},{"issue":"3","key":"8430_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.clnu.2013.01.004","volume":"32","author":"JM Argiles","year":"2013","unstructured":"Argiles JM, Anguera A, Stemmler B (2013) A new look at an old drug for the treatment of cancer cachexia: megestrol acetate. Clin Nutr 32(3):319\u2013324","journal-title":"Clin Nutr"},{"issue":"1\u20132","key":"8430_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0014-2999(94)90229-1","volume":"265","author":"HD McCarthy","year":"1994","unstructured":"McCarthy HD, Crowder RE, Dryden S, Williams G (1994) Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations. Eur J Pharmacol 265(1\u20132):99\u2013102","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"8430_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0959-8049(96)00486-8","volume":"33","author":"G Mantovani","year":"1997","unstructured":"Mantovani G, Maccio A, Esu S, Lai P, Santona MC, Massa E et al (1997) Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia\/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur J Cancer 33(4):602\u2013607","journal-title":"Eur J Cancer"},{"issue":"2","key":"8430_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1615\/CritRevOncog.v9.i2.10","volume":"9","author":"G Mantovani","year":"1998","unstructured":"Mantovani G, Maccio A, Lai P, Massa E, Ghiani M, Santona MC (1998) Cytokine involvement in cancer anorexia\/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms. Crit Rev Oncog 9(2):99\u2013106","journal-title":"Crit Rev Oncog"},{"issue":"11","key":"8430_CR15","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0959-8049(98)00219-6","volume":"34","author":"F De Conno","year":"1998","unstructured":"De Conno F, Martini C, Zecca E, Balzarini A, Venturino P, Groff L et al (1998) Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. Eur J Cancer 34(11):1705\u20131709","journal-title":"Eur J Cancer"},{"issue":"2","key":"8430_CR16","first-page":"74","volume":"2","author":"E Bruera","year":"1998","unstructured":"Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J et al (1998) Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Cancer Prev Control 2(2):74\u201378","journal-title":"Cancer Prev Control"},{"issue":"4","key":"8430_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1200\/JCO.1993.11.4.762","volume":"11","author":"CL Loprinzi","year":"1993","unstructured":"Loprinzi CL, Michalak JC, Schaid DJ, Mailliard JA, Athmann LM, Goldberg RM et al (1993) Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and\/or cachexia. J Clin Oncol 11(4):762\u2013767","journal-title":"J Clin Oncol"},{"issue":"12","key":"8430_CR18","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1200\/JCO.2004.06.024","volume":"22","author":"A Jatoi","year":"2004","unstructured":"Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N et al (2004) An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22(12):2469\u20132476","journal-title":"J Clin Oncol"},{"issue":"4","key":"8430_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpainsymman.2003.09.007","volume":"27","author":"AP L\u00f3pez","year":"2004","unstructured":"L\u00f3pez AP, i Figuls MR, Cuchi GU, Berenstein EG, Pasies BA, Alegre MB et al (2004) Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage 27(4):360\u2013369","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"8430_CR20","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00520-018-4047-y","volume":"26","author":"B Kouchaki","year":"2018","unstructured":"Kouchaki B, Janbabai G, Alipour A, Ala S, Borhani S, Salehifar E (2018) Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. Support Care Cancer 26(7):2479\u20132489","journal-title":"Support Care Cancer"},{"issue":"4","key":"8430_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00000421-199808000-00006","volume":"21","author":"C Vadell","year":"1998","unstructured":"Vadell C, Segui MA, Gimenez-Arnau JM, Morales S, Cirera L, Bestit I et al (1998) Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Am J Clin Oncol 21(4):347\u2013351","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"8430_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/jcsm.12292","volume":"9","author":"V Ruiz-Garcia","year":"2018","unstructured":"Ruiz-Garcia V, Lopez-Briz E, Carbonell-Sanchis R, Bort-Marti S, Gonzalvez-Perales JL (2018) Megestrol acetate for cachexia-anorexia syndrome. A systematic review. J Cachexia Sarcopenia Muscle 9(3):444\u2013452","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"8430_CR23","doi-asserted-by":"publisher","first-page":"1143S","DOI":"10.3945\/ajcn.2010.28608E","volume":"91","author":"NP Gullett","year":"2010","unstructured":"Gullett NP, Hebbar G, Ziegler TR (2010) Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. Am J Clin Nutr 91(4):1143S-1147S","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"8430_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0899-9007(99)00007-6","volume":"15","author":"E Koller","year":"1999","unstructured":"Koller E, Gibert C, Green L, Mann M, Bernstein B (1999) Thrombotic events associated with megestrol acetate in patients with AIDS cachexia. Nutrition 15(4):294\u2013298","journal-title":"Nutrition"},{"key":"8430_CR25","doi-asserted-by":"crossref","unstructured":"Ruiz Garcia V, Lopez-Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort-Marti S (2013) Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2013(3):CD004310","DOI":"10.1002\/14651858.CD004310.pub3"},{"issue":"23","key":"8430_CR26","doi-asserted-by":"publisher","first-page":"10165","DOI":"10.7314\/APJCP.2014.15.23.10165","volume":"15","author":"C Ordu","year":"2014","unstructured":"Ordu C, Pilanci KN, Koksal UI, Okutur K, Saglam S, Tecimer C et al (2014) Can megestrol acetate induce thrombosis in advanced oncology patients receiving chemotherapy? Asian Pac J Cancer Prev 15(23):10165\u201310169","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"8430_CR27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.2517-6161.1951.tb00088.x","volume":"13","author":"EH Simpson","year":"1951","unstructured":"Simpson EH (1951) The interpretation of interaction in contingency tables. J R Stat Soc Series B Stat Methodol 13(2):238\u2013241","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"8430_CR28","unstructured":"The Korea Ministry of Food and Drug Safety (2018) Megestrol acetate. https:\/\/nedrug.mfds.go.kr\/pbp\/CCBBB01\/getItemDetailCache?cacheSeq=201800533aupdateTs2024-02-02%2019:41:59.0b. Accessed 2 Mar 2024"},{"issue":"2","key":"8430_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clnu.2011.10.005","volume":"31","author":"C Madeddu","year":"2012","unstructured":"Madeddu C, Dessi M, Panzone F, Serpe R, Antoni G, Cau MC et al (2012) Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib +\/- megestrol acetate for patients with cancer-related anorexia\/cachexia syndrome. Clin Nutr 31(2):176\u2013182","journal-title":"Clin Nutr"},{"key":"8430_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-017-0155-z","volume":"16","author":"KL Wang","year":"2018","unstructured":"Wang KL, Yap ES, Goto S, Zhang S, Siu CW, Chiang CE (2018) The diagnosis and treatment of venous thromboembolism in asian patients. Thromb J 16:4","journal-title":"Thromb J"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08430-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08430-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08430-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T20:10:00Z","timestamp":1731615000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08430-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["8430"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08430-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3241216\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Gyeongsang National University Changwon Hospital (GNUCH 2019\u201311-027) and was conducted in accordance with the principles of the Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not available.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}